NASDAQ: ANNXAnnexon Inc Stock Ownership - Who owns Annexon?
Insider buying vs selling
Have Annexon Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| William H. Carson | Director | 2025-12-01 | 4,115 | $4.47 | $18.39kBuy |
| Jung Choi | Director | 2025-12-01 | 33,000 | $4.19 | $138.27kBuy |
| Muneer A. Satter | Director | 2025-11-21 | 422,613 | $4.28 | $1.81MBuy |
| Muneer A. Satter | Director | 2025-11-20 | 400,000 | $4.48 | $1.79MBuy |
| Muneer A. Satter | Director | 2025-11-19 | 500,000 | $3.94 | $1.97MBuy |
| Muneer A. Satter | Director | 2025-11-18 | 500,000 | $3.18 | $1.59MBuy |
| Muneer A. Satter | Director | 2025-11-17 | 500,000 | $2.99 | $1.50MBuy |
| William H. Carson | Director | 2025-10-30 | 4,115 | $3.17 | $13.04kBuy |
| William H. Carson | Director | 2025-09-30 | 4,115 | $3.05 | $12.55kBuy |
| William H. Carson | Director | 2025-09-02 | 4,115 | $2.09 | $8.60kBuy |
ANNX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when ANNX insiders and whales buy or sell their stock.
ANNX Shareholders
What type of owners hold Annexon Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Bain Capital Life Sciences Investors LLC | 9.28% | 11,103,852 | $45.08M | Insider |
| Fmr LLC | 9.26% | 11,081,163 | $44.99M | Institution |
| Muneer A. Satter | 8.13% | 9,728,637 | $39.50M | Insider |
| Blackrock Inc | 6.60% | 7,899,008 | $32.07M | Institution |
| Bvf Inc | 5.85% | 7,000,000 | $28.42M | Institution |
| Redmile Group LLC | 5.27% | 6,300,644 | $25.58M | Institution |
| Vanguard Group Inc | 4.88% | 5,835,112 | $23.69M | Institution |
| Bain Capital Life Sciences Investors LLC | 4.39% | 5,249,069 | $21.31M | Institution |
| Bellevue Group Ag | 4.31% | 5,157,290 | $20.94M | Institution |
| Morgan Stanley | 2.53% | 3,029,848 | $12.30M | Institution |
ANNX vs Biotech Stocks
Annexon Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.